Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10557-020-07024-7 http://scihub22266oqcxt.onion/10.1007/s10557-020-07024-7 32557011!7297930!32557011     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cardiovasc+Drugs+Ther 2021 ; 35 (2): 205-214 Nephropedia Template TP {{tp|p=32557011|t=2021. A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs |pdf=|usr=}}{{32557011}} gab.com Text A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs JO: Cardiovasc Drugs Ther http://www.kidney.de/pget.php?&tw=1&pmid=32557011 #FOAvip Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). COVID-19 significantly affects multiple systems including the cardiovascular system. Most importantly, in addition to the direct injury from the virus per se, the subsequent cytokine storm, an overproduction of immune cells and their activating compounds, causes devastating damage. To date, emerging anti-SARS-CoV-2 treatments are warranted to control epidemics. Several candidate drugs have been screened and are currently under investigation. These primarily include antiviral regimens and immunomodulatory regimens. However, beyond the anti-SARS-CoV-2 effects, these drugs may also have risks to the cardiovascular system, especially altering cardiac conduction. Herein, we review the cardiovascular risks of potential anti-COVID-19 drugs. Twit Text FOAVip A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs ????Cardiovasc Drugs Ther http://www.kidney.de/pget.php?&tw=1&pmid=32557011 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32557011 #FOAvip English Wikipedia <ref>{{Cite pmid|32557011}}</ref> A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs #MMPMID32557011 Yu WL; Toh HS; Liao CT; Chang WT Cardiovasc Drugs Ther 2021[Apr]; 35 (2): 205-214 PMID32557011show ga Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). COVID-19 significantly affects multiple systems including the cardiovascular system. Most importantly, in addition to the direct injury from the virus per se, the subsequent cytokine storm, an overproduction of immune cells and their activating compounds, causes devastating damage. To date, emerging anti-SARS-CoV-2 treatments are warranted to control epidemics. Several candidate drugs have been screened and are currently under investigation. These primarily include antiviral regimens and immunomodulatory regimens. However, beyond the anti-SARS-CoV-2 effects, these drugs may also have risks to the cardiovascular system, especially altering cardiac conduction. Herein, we review the cardiovascular risks of potential anti-COVID-19 drugs. |*COVID-19 Drug Treatment[MESH] |*COVID-19/immunology[MESH] |Antiviral Agents/*pharmacology[MESH] |Cardiotoxicity/*prevention & control[MESH] |Cardiovascular System/*drug effects[MESH] |Humans[MESH] |Immunologic Factors/*pharmacology[MESH] |Risk Assessment[MESH]A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-1(epmc).pdf DeepDyve Pubget Overpricing